The clinical effect of virtual reality- and inhibitory learning-based dynamic exposure therapy for panic disorder and agoraphobia

Hallym University Medical Center- Chuncheon0 个研究点目标入组 90 人开始时间: 待定最近更新: 2023年4月4日

试验速览

暂无简介。

•a) Aged 18 to 64
•b) Patients: Diagnosed with Panic Disorder (E) or Agoraphobia (F) by the Mini-International Neuropsychiatric Interview (MINI). / Healthy: No current psychiatric disorders including panic disorder and agoraphobia
•c) Enough verbal and cognitive abilities to understand the consent form, answer the questionnaire, and operate VR devices/programs
•d) Received detailed explanation regarding the study, adequately understood them, and volunteerly decided and give consent to participate in the study

•a) Patient: Moderate or more suicide tendency (C), current manic (not hypomanic) episode (D), current/lifetime psychotic disorders (L), or psychopathy (P) is diagnosed in the MINI. Or past diagnosis records of psychotic disorders or severe bipolar disorder. / Healthy: Current significant psychiatric disorders
•b) Suicide attempts within recent six months
•c) Current/past epilepsy or photosensitive syndrome
•d) Visual impairment (except for correctable ametropia or dyschromatopsia)
•e) auditory disorders or moderate or severe hearing loss
•f) Impairment of voluntary movements that may hinder the operation of VR programs
•g) Serious clinical problems in the cardiovascular system, digestive system, respiratory system, endocrine system, or central nervous system that make it difficult to participate in the study
•H) Pregnant or lactating women
•I) Those who are judged unsuitable for research due to other reasons by principal investigators or those in charge

发起方

Hallym University Medical Center- Chuncheon